Effects of huoxin formula on the arterial functions of patients with coronary heart disease

References

• Blankenberg S, Luc G, Ducimetiere P, Arveiler D, Ferrieres J, Amouyel P, Evans A, Cambien F, Tiret L, Group PS. 2003. Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation. 108:2453–2459.
   PubMed Web of Science ®Google Scholar
• Chan JY, Koon JC, Leung PC, Che CT, Fung KP. 2011. Suppression of low-density lipoprotein oxidation, vascular smooth muscle cell proliferation and migration by a herbal extract of Radix Astragali, Radix Codonopsis and Cortex Lycii. BMC Complement Altern Med. 11:32.
   PubMed Web of Science ®Google Scholar
• Chan P, Thomas GN, Tomlinson B. 2002. Protective effects of trilinolein extracted from Panax notoginseng against cardiovascular disease. Acta Pharmacologica Sinica. 23:1157–1162.
   PubMed Web of Science ®Google Scholar
• Chen YY, Li Q, Pan CS, Yan L, Fan JY, He K, Sun K, Liu YY, Chen QF, Bai Y, et al. 2015. QiShenYiQi Pills, a compound in Chinese medicine, protects against pressure overload-induced cardiac hypertrophy through a multi-component and multi-target mode. Sci Rep. 5:11802.
   PubMed Web of Science ®Google Scholar
• Chinese Society of Cardiology CMA; Editorial Board CJoC. 2007. [Guideline for diagnosis and treatment of patients with chronic stable angina (no abstract)]. Zhonghua Xin Xue Guan Bing Za Zhi. 35:195–206.
   PubMedGoogle Scholar
• Cobble M. 2014. Coronary heart disease in women. J Fam Pract. 63:S9–S14.
   PubMed Web of Science ®Google Scholar
• Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, Kyriakopoulos A. 1993. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol. 171:223–229.
   PubMed Web of Science ®Google Scholar
• de Boer OJ, van der Meer JJ, Teeling P, van der Loos CM, Idu MM, van Maldegem F, Aten J, van der Wal AC. 2010. Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques. J Pathol. 220:499–508.
   PubMed Web of Science ®Google Scholar
• Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G, Atherosclerosis Risk in Communities S. 2003. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes. 52:1799–1805.
   PubMed Web of Science ®Google Scholar
• Fotis L, Agrogiannis G, Vlachos IS, Pantopoulou A, Margoni A, Kostaki M, Verikokos C, Tzivras D, Mikhailidis DP, Perrea D. 2012. Intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 at the early stages of atherosclerosis in a rat model. In Vivo. 26:243–250.
   PubMed Web of Science ®Google Scholar
• Furtado MV, Rossini AP, Campani RB, Meotti C, Segatto M, Vietta G, Polanczyk CA. 2009. Interleukin-18: an independent predictor of cardiovascular events in patients with acute coronary syndrome after 6 months of f follow-up. Coron Artery Dis. 20:327–331.
   PubMed Web of Science ®Google Scholar
• Hadi HA, Carr CS, Al Suwaidi J. 2005. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag. 1:183–198.
   PubMedGoogle Scholar
• Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. 1997. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet. 349:462–466.
   PubMed Web of Science ®Google Scholar
• Hu QX. 2009. The intervention of myocardial angiogenesis and huoxin formula in coronary heart disease. Shanghai University of Traditional Chinese Medicine. Chinese PhD Thesis: http://med.wanfangdata.com.cn/Paper/Detail/DegreePaper_Y1590538.
   Google Scholar
• Hung CS, Li HY, Kuo CH, Lin MS, Kuo TC, Tsai SJ, Liu PH, Lin CH, Yang CY, Chuang LM, et al. 2015. Fasting but not changes of plasma metabolome during oral glucose tolerance tests improves the diagnosis of severe coronary arterial stenosis. Clin Endocrinol (Oxf). 83:483–489.
   PubMed Web of Science ®Google Scholar
• Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM, Jr, Boerwinkle E. 1997. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 96:4219–4225.
   PubMed Web of Science ®Google Scholar
• Insull W. Jr. 2009. The pathology of atherosclerosis: plaque development and plaque responses to medical treatment. Am J Med. 122:S3–S14.
   PubMed Web of Science ®Google Scholar
• Jude EB, Douglas JT, Anderson SG, Young MJ, Boulton AJ. 2002. Circulating cellular adhesion molecules ICAM-1, VCAM-1, P- and E-selectin in the prediction of cardiovascular disease in diabetes mellitus. Eur J Intern Med. 13:185–189.
   PubMedGoogle Scholar
• Ku SK, Kim JA, Han CK, Bae JS. 2013. Antithrombotic activities of epi-sesamin in vitro and in vivo. Am J Chin Med. 41:1313–1327.
   PubMed Web of Science ®Google Scholar
• Kuo HL, Chou CY, Liu YL, Yang YF, Huang CC, Lin HH. 2008. Reduction of pro-inflammatory cytokines through hemodiafiltration. Ren Fail. 30:796–800.
   PubMed Web of Science ®Google Scholar
• Lee DS, Kim KS, Ko W, Li B, Keo S, Jeong GS, Oh H, Kim YC. 2014. The neoflavonoid latifolin isolated from MeOH extract of Dalbergia odorifera attenuates inflammatory responses by inhibiting NF-κB activation via Nrf2-mediated heme oxygenase-1 expression. Phytother Res. 28:1216–1223.
   PubMed Web of Science ®Google Scholar
• Lee SH, Kim JY, Seo GS, Kim YC, Sohn DH. 2009. Isoliquiritigenin, from Dalbergia odorifera, up-regulates anti-inflammatory heme oxygenase-1 expression in RAW264.7 macrophages. Inflamm. Res. 58:257–262.
   PubMed Web of Science ®Google Scholar
• Lee W, Ku SK, Min BW, Lee S, Jee JG, Kim JA, Bae JS. 2014. Vascular barrier protective effects of pellitorine in LPS-induced inflammation in vitro and in vivo. Fitoterapia. 92:177–187.
   PubMed Web of Science ®Google Scholar
• Li J, Shao ZH, Xie JT, Wang CZ, Ramachandran S, Yin JJ, Aung H, Li CQ, Qin G, Vanden Hoek T, et al. 2012. The effects of ginsenoside Rb1 on JNK in oxidative injury in cardiomyocytes. Arch Pharm Res. 35:1259–1267.
   PubMed Web of Science ®Google Scholar
• Li J, Xie ZZ, Tang YB, Zhou JG, Guan YY. 2011. Ginsenoside-Rd, a purified component from Panax notoginseng saponins, prevents atherosclerosis in apoE knockout mice. Eur J Pharmacol. 652:104–110.
   PubMed Web of Science ®Google Scholar
• Li Q, Li Z, Zhang X, Ruan Y, Qiu J. 2014. Evaluated plasma interleukin-18/interleukin-10 ratio is a risk factor for acute coronary syndromes in patients with stable angina pectoris. Cardiol J. 21:83–88.
   PubMed Web of Science ®Google Scholar
• Lim KH, Lim DJ, Kim JH. 2013. Ginsenoside-Re ameliorates ischemia and reperfusion injury in the heart: a hemodynamics approach. J Ginseng Res. 37:283–292.
   PubMed Web of Science ®Google Scholar
• Luc G, Arveiler D, Evans A, Amouyel P, Ferrieres J, Bard JM, Elkhalil L, Fruchart JC, Ducimetiere P, Group PS. 2003. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study. Atherosclerosis. 170:169–176.
   PubMed Web of Science ®Google Scholar
• Nishimura S, Manabe I, Nagasaki M, Kakuta S, Iwakura Y, Takayama N, Ooehara J, Otsu M, Kamiya A, Petrich BG, et al. 2012. In vivo imaging visualizes discoid platelet aggregations without endothelium disruption and implicates contribution of inflammatory cytokine and integrin signaling. Blood. 119:e45–e56.
   PubMed Web of Science ®Google Scholar
• Nold M, Goede A, Eberhardt W, Pfeilschifter J, Muhl H. 2003. IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1: suppression by TNF alpha blockage and modulation by IL-10. Naunyn Schmiedebergs Arch Pharmacol. 367:68–75.
   PubMed Web of Science ®Google Scholar
• O'Flaherty M, Ford E, Allender S, Scarborough P, Capewell S. 2008. Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults. Heart. 94:178–181.
   PubMed Web of Science ®Google Scholar
• Ridker PM. 1998. Intercellular adhesion molecule (ICAM-1) and the risks of developing atherosclerotic disease. Eur Heart J. 19:1119–1121.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. 1998. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet. 351:88–92.
   PubMed Web of Science ®Google Scholar
• Ross R, Glomset J, Harker L. 1977. Response to injury and atherogenesis. Am J Pathol. 86:675–684.
   PubMed Web of Science ®Google Scholar
• Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CM, Golden SH, Folsom AR, Chambless LE; Atherosclerosis Risk in Communities I. 2005. Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care. 28:2013–2018.
   PubMed Web of Science ®Google Scholar
• Singh RB, Mengi SA, Xu YJ, Arneja AS, Dhalla NS. 2002. Pathogenesis of atherosclerosis: a multifactorial process. Exp Clin Cardiol. 7:40–53.
   PubMedGoogle Scholar
• Sugiyama A, Zhu BM, Takahara A, Satoh Y, Hashimoto K. 2002. Cardiac effects of Salvia miltiorrhiza/Dalbergia odorifera mixture, an intravenously applicable Chinese medicine widely used for patients with ischemic heart disease in China. Circ J. 66:182–184.
   PubMed Web of Science ®Google Scholar
• Tarantino G, Costantini S, Finelli C, Capone F, Guerriero E, La Sala N, Gioia S, Castello G. 2014. Is serum interleukin-17 associated with early atherosclerosis in obese patients? J Transl Med. 12:214.
   PubMed Web of Science ®Google Scholar
• van Bruggen N, Ouyang W. 2014. Th17 cells at the crossroads of autoimmunity, inflammation, and atherosclerosis. Immunity. 40:10–12.
   PubMed Web of Science ®Google Scholar
• Weber C, Noels H. 2011. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med. 17:1410–1422.
   PubMed Web of Science ®Google Scholar
• Wei JR, Wen X, Bible PW, Li Z, Nussenblatt RB, Wei L. 2017. Panax notoginseng saponin controls IL-17 expression in helper T cells. J Ocul Pharmacol Ther . 33:285–289.
   PubMed Web of Science ®Google Scholar
• Wilson EM, Gunasinghe HR, Coker ML, Sprunger P, Lee-Jackson D, Bozkurt B, Deswal A, Mann DL, Spinale FG. 2002. Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure. J Card Fail. 8:390–398.
   PubMed Web of Science ®Google Scholar
• Xiao XY, Zhang Y. 2017. Literature analysis of drug-induced liver injury caused by Chinese herbal medicine in 169 cases. Lishizhen Med Materia Medica Res. 28:1022–1024.
   Google Scholar
• Xie JT, Shao ZH, Vanden Hoek TL, Chang WT, Li J, Mehendale S, Wang CZ, Hsu CW, Becker LB, Yin JJ, et al. 2006. Antioxidant effects of ginsenoside Re in cardiomyocytes. Eur J Pharmacol. 532:201–207.
   PubMed Web of Science ®Google Scholar
• Yu SM, Kuo SC. 1995. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta. Br J Pharmacol. 114:1587–1594.
   PubMed Web of Science ®Google Scholar
• Zhang LL, Lu SF, Zhang S, Nie HG, Guan ZZ, Yang BF. 2006. [Effect of asarinin on the acute heart transplantation rejection and the expression of adhesion molecule]. Zhongguo Zhong Yao Za Zhi. 31:494–497.
   PubMedGoogle Scholar
• Zhang W, Zhang J, Zhang M, Nie L. 2014. Protective effect of Asarum extract in rats with adjuvant arthritis. Exp Ther Med. 8:1638–1642.
   PubMed Web of Science ®Google Scholar
• Zhang YG, Zhang HG, Zhang GY, Fan JS, Li XH, Liu YH, Li SH, Lian XM, Tang Z. 2008. Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory action. Clin Exp Pharmacol Physiol. 35:1238–1244.
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Zhang XL, Li MH, Iqbal J, Bourantas CV, Li JJ, Su XY, Muramatsu T, Tian NL, Chen SL. 2013. The ginsenoside Rg1 prevents transverse aortic constriction-induced left ventricular hypertrophy and cardiac dysfunction by inhibiting fibrosis and enhancing angiogenesis. J Cardiovasc Pharmacol. 62:50–57.
   PubMed Web of Science ®Google Scholar
• Zhu HY, Gao YH, Wang ZY, Xu B, Wu AM, Xing YW, Liu B, Lou LX, Chen LX. 2013. Astragalus polysaccharide suppresses the expression of adhesion molecules through the regulation of the p38 MAPK signaling pathway in human cardiac microvascular endothelial cells after ischemia-peperfusion injury. Evid Based Complement Alternat Med. 2013:280493.
   PubMed Web of Science ®Google Scholar